The growth capacity of bone marrow CD34 positive cells in culture is drastically reduced in a murine model of Down syndrome.
Human trisomy 21, Down syndrome (DS), is characterized by mental retardation. In addition, high risks of developing hematological and immune disorders, as well as cardiac, skeletal and other abnormalities are life-long concerns. Recent data suggested that bone marrow contains progenitors, hematopoietic or stromal cells, which may have the potential of generating non hematopoietic tissue such as neural cells, cardiac cells or osteoblasts. Therefore we have used a model of Down syndrome, Ts65Dn mice, to investigate their bone marrow. We have found that the vast majority of CD34(+) cells in the bone marrow of adult Ts65Dn mice, but not of the CD34(-) cells, exhibit a drastic reduction in their in vitro growth capacity. In addition to neural antigens, cultured CD34(+) cells from trisomic and diploid mice also expressed mast cell markers.
Jablonska
Beata
B
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore Street, Baltimore, MD 21201, USA.
Ford
David
D
Trisler
David
D
Pessac
Bernard
B
D000818:Animals; D018952:Antigens, CD34 / Q000032:analysis*; D017209:Apoptosis; D001854:Bone Marrow Cells / Q000276:immunology / Q000473:pathology*; D002455:Cell Division; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000473:pathology*; D020287:In Situ Nick-End Labeling; D051379:Mice
D018952:Antigens, CD34